Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

Fig. 3

Forest plot and pooled HR and 95 % CI for OS (a) and PFS (b): anti-angiogenesis therapy versus non-anti-angiogenesis therapy. The pooled HR for OS and PFS showed that the patients receiving anti-angiogenesis therapy possessed a significant improvement in OS and PFS. HR hazard ratios, OS overall survival, PFS progression-free survival, CI confidence intervals

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us